(Reuters) – United Therapeutics Corp said on Monday the U.S. Food and Drug Administration had declined to approve the company’s drug to treat a type of lung disease, citing an inspection issue at a third-party facility.
(Reporting by Manas Mishra in Bengaluru; Editing by Ramakrishnan M.)
